Bowel Cleanliness
Conditions
Brief summary
A Confirmation of Safety, Tolerance and Efficacy of PICOPREP in Clinical Practice.
Interventions
None listed
Sponsors
Ferring Pharmaceuticals
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients eligible for treatment with PICOPREP® for bowel cleansing prior to endoscopic examination or surgery
Exclusion criteria
* Patients in which prescription of PICOPREP® is contraindicated
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Frequency of Adverse Events | 2 days |
| The Severity of Adverse Events | 2 days |
Secondary
| Measure | Time frame |
|---|---|
| Treatment efficacy measured by assessment of the quality of colon cleaning | 2 days |
Countries
Czechia
Outcome results
None listed